SavedAdd your journal

Journals / GORM:Gynecology Obstetrics & Reproductive Medicine / 2004 / Cilt: 10 - Sayı: 1

Maternal and perinatal mortality and morbidity in pregnant women with partial and complete HELLP Syndrome

Nur DOKUZEYLÜL
Selçuk ÖZDEN
Vedat DAYICIOĞLU
Pages
27–32
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It may be possible to decrease maternal-perinatal mortality and morbidity by timely interference adjusted before the formation of HELLP criteria.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: To detect maternal-perinatal mortality and morbidity in pregnant women with partial and complete (classical) HELLP syndrome.
📊
Key Findings & Data:STUDY DESIGN: Forty-two pregnant women having classical triad of HELLP syndrome (i.e., H: hemolysis, EL: elevated liver enzymes, LP: low platelet), 189 pregnant women having one or two criteria of HELLP syndrome (i.e. partial HELLP syndrome) and 34 preeclamptic pregnant women without HELLP syndrome were evaluated prospectively.
💡
Conclusion & Impact:It may be possible to decrease maternal-perinatal mortality and morbidity by timely interference adjusted before the formation of HELLP criteria.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:HELLP sendromu · Bebek ölüm oranı · Ana ölüm oranı

Abstract

OBJECTIVE: To detect maternal-perinatal mortality and morbidity in pregnant women with partial and complete (classical) HELLP syndrome. STUDY DESIGN: Forty-two pregnant women having classical triad of HELLP syndrome (i.e., H: hemolysis, EL: elevated liver enzymes, LP: low platelet), 189 pregnant women having one or two criteria of HELLP syndrome (i.e. partial HELLP syndrome) and 34 preeclamptic pregnant women without HELLP syndrome were evaluated prospectively. Cases with partial HELLP syndrome were divided in to three subgroups according to the existing criteria ( H, HEL, HLP). RESULTS: The rates of abnormal clinical, laboratory findings, need for administration of corticosteroids, need for neonatal intensive care unite were found to be increased in relationship with the increasing number of HELLP criteria. CONCLUSION: Maternal-perinatal mortality and morbidity were found to be lower in cases with partial HELLP syndrome than cases with complete HELLP syndrome, but to be higher than the cases without criteria of the syndrome. Low platelet count was found to be the most significant factor related with maternal-perinatal mortality. It may be possible to decrease maternal-perinatal mortality and morbidity by timely interference adjusted before the formation of HELLP criteria.

🔖

Cite This Article

DOKUZEYLÜL, N., ÖZDEN, S., DAYICIOĞLU, V. (2004). Maternal and perinatal mortality and morbidity in pregnant women with partial and complete HELLP Syndrome. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 10 - Sayı: 1, 27–32. https://ajindex.com/articles/227156

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142:159-67
  2. Audibert F, Friedman SA, Sibai BM. Clinical utility of strict diagnostic criteria for the HELLP syndrome. Am J Obstet Gynecol. 1996; 175:460-4
  3. Martin JN Jr, Blake PG, Perry KGJr, et al. The natural history of HELLP syndrome:patterns of disease progression and regression. Am J Obstet Gynecol 1991; 164:1500-13
  4. Barton JR, Sibai BM. Care of pregnancy complicated by HELLP syndrome. Obstet Clin North Am. 1991; 18:165-81
  5. Dayıcıoğlu V, Özden S, Oral B: HELLP sendromu (Derleme) Zeynep Kamil Tıp Bülteni. 1997; 29:71-86
  6. Martin JR Jr, Magann EF. Hellp syndrome: Current principles and recommended practices. In: Lee RV, Barron WM, Cotton DB, Coustan D (eds). Volume2: current obstetric medicine. 2 nd ed. St Jouis: Mosby- Year Book; 1996:129-75
  7. Egerman RS, Sibai BM. HELLP syndrome. Clin Obstet Gynecol 1999; 42:381-90
  8. Ananth CV, Sovitz DA, Bowes VA. Hypertensive disorders of pregnancy and stillbirth in North Carolina 1988 to 1991. Acta Obstet Gynecol Scand 1995; 74:778-93
  9. Sibai BM, Taslimi MM, Nazer AE, Amon E. Maternalperinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia- eclampsia. Am J Obstet Gynecol 1986; 155:501-9
  10. Roberts JM. Pregnancy related hypertension. In Creasy Resnik (ed): Maternal- Fetal Medicine 4th Edition Philadelphia: W.B. Saunders, 1999:833-72
  11. Cunningham FG, Mac Donald PC, Gant NF, Leveno KJ, Gilstrap III LC, Hawkins G DV and Clark SL (eds). Hypertensive Disorders in Pregnancy. Williams Obstetrics, Prentice-Hall Norwalk, 20th edition. 1997:693-744
  12. Willams KP, Wilson S. Ethnic variation in the incidence of HELLP syndrome in a hypertensive pregnant population. J Perinat Med 1997; 25:498-501
  13. Magann E, Martin J. The laboratory evaluation of hypertensive gravidas. Obstet Gynecol Survey 1995; 50:138-45
  14. Sullivan CA, Magann EF, Perry KG. The recurrence risk at the syndrome of hemolysis, elevated liver enzymes and low platelets in subsequent gestations. Am J Obstet Gynecol 1994; 171:940-3
  15. Sibai BM, Ramadan MK, Chari RS. Pregnancies complicated by HELLP syndrome: Subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol 1995; 172:125-9
  16. Magann E, Perryk, Meydrech E. Postpartum corticosteroids: Accelerated recovery from HELLP. Am J Obstet Gyne